文献速递甲状腺疾病

基于全基因组DNA甲基化谱的预后分类器在分化良好的甲状腺肿瘤中的研究

Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该研究对50例非肿瘤甲状腺组织、17例良性甲状腺病变和74例甲状腺癌进行全基因组DNA甲基化检测,构建了基于21个DNA甲基化探针的预后分类器,用于预测分化良好的甲状腺癌患者的不良结局。内部数据灵敏度63%、特异度92%,TCGA数据灵敏度64%、特异度88%,高风险评分是不良结局的独立因素(Cox回归,P < 0.001)。

要点

  • 基于21个DNA甲基化探针的预后分类器可预测分化良好的甲状腺癌患者的不良结局。
  • 内部数据灵敏度63%、特异度92%;TCGA数据灵敏度64%、特异度88%。
  • 基于分类器的高风险评分是不良结局的独立因素(Cox回归,P < 0.001)。

核心结论

  • 甲状腺病变的甲基化谱根据组织学亚型呈现特异性特征。
  • 由21个探针组成的有意义的算法能够预测分化良好的甲状腺癌的复发。

研究设计与样本

  • 研究对50例非肿瘤甲状腺组织、17例良性甲状腺病变和74例甲状腺癌(60例乳头状癌、8例滤泡状癌、2例Hürthle细胞癌、1例低分化癌和3例未分化癌)进行了全基因组DNA甲基化检测(450k平台,Illumina)。
  • 通过对角线性判别分析开发了用于分化良好的甲状腺癌的预后分类器。
  • 结果与癌症基因组图谱(TCGA)数据库进行了比较。

主要发现

  • 根据每种组织学亚型检测到特定的表观遗传谱。
  • 与NTs相比,BTLs和滤泡状癌显示更多的甲基化CpG,而乳头状癌和未分化癌以低甲基化为主。

关键数值与推荐

  • 基于21个DNA甲基化探针的预后分类器能够预测分化良好的甲状腺癌患者的不良结局(内部数据灵敏度63%、特异度92%;TCGA数据灵敏度64%、特异度88%)。
  • 基于分类器的高风险评分被认为是不良结局的独立因素(Cox回归,P < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Even though the majority of well-differentiated thyroid carcinoma (WDTC) is indolent, a number of cases display an aggressive behavior. Cumulative evidence suggests that the deregulation of DNA methylation has the potential to point out molecular markers associated with worse prognosis. OBJECTIVE: To identify a prognostic epigenetic signature in thyroid cancer. DESIGN: Genome-wide DNA methylation assays (450k platform, Illumina) were performed in a cohort of 50 nonneoplastic thyroid tissues (NTs), 17 benign thyroid lesions (BTLs), and 74 thyroid carcinomas (60 papillary, 8 follicular, 2 Hürthle cell, 1 poorly differentiated, and 3 anaplastic). A prognostic classifier for WDTC was developed via diagonal linear discriminant analysis. The results were compared with The Cancer Genome Atlas (TCGA) database. RESULTS: A specific epigenetic profile was detected according to each histological subtype. BTLs and follicular carcinomas showed a greater number of methylated CpG in comparison with NTs, whereas hypomethylation was predominant in papillary and undifferentiated carcinomas. A prognostic classifier based on 21 DNA methylation probes was able to predict poor outcome in patients with WDTC (sensitivity 63%, specificity 92% for internal data; sensitivity 64%, specificity 88% for TCGA data). High-risk score based on the classifier was considered an independent factor of poor outcome (Cox regression, P < 0.001). CONCLUSIONS: The methylation profile of thyroid lesions exhibited a specific signature according to the histological subtype. A meaningful algorithm composed of 21 probes was capable of predicting the recurrence in WDTC.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bisarro Dos Reis M, Barros-Filho MC, Marchi FA, et al. Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017. PMID: 28938489. doi:10.1210/jc.2017-00881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。